MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

NEOG

9.92

+0.61%↑

Search

Teleflex Inc

Fechado

SetorSaúde

105.06 2.09

Visão Geral

Variação de preço das ações

24h

Atual

Mín

102

Máximo

106.74

Indicadores-chave

By Trading Economics

Rendimento

-531M

-409M

Vendas

132M

913M

P/E

Médio do Setor

28.636

89.037

Rendimento de Dividendos

1.3

Margem de lucro

-44.785

Funcionários

14,100

EBITDA

-546M

-323M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+29.37% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

1.30%

2.18%

Próximos Ganhos

26 de fev. de 2026

Próxima data de dividendos

16 de mar. de 2026

Próxima data de ex-dividendo

6 de mar. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-877M

4.6B

Abertura anterior

102.97

Fecho anterior

105.06

Sentimento de Notícias

By Acuity

50%

50%

174 / 360 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Teleflex Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

22 de jan. de 2026, 21:55 UTC

Ganhos

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 de jan. de 2026, 23:52 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 de jan. de 2026, 23:42 UTC

Conversa de Mercado

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 de jan. de 2026, 23:40 UTC

Conversa de Mercado

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 de jan. de 2026, 23:30 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 de jan. de 2026, 23:30 UTC

Conversa de Mercado

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 de jan. de 2026, 22:37 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 de jan. de 2026, 21:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

22 de jan. de 2026, 21:44 UTC

Ganhos

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 de jan. de 2026, 21:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 de jan. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 de jan. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 de jan. de 2026, 21:30 UTC

Ganhos

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One To Acquire Brex >COF

22 de jan. de 2026, 21:13 UTC

Ganhos

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 de jan. de 2026, 21:11 UTC

Ganhos

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 de jan. de 2026, 21:10 UTC

Ganhos

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 de jan. de 2026, 21:06 UTC

Ganhos

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Rev $15.58B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q EPS $3.26 >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Net Interest Margin 8.26% >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Net $2.13B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Adj EPS $3.86 >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Capital One 4Q Net Charge-Offs $3.8B >COF

22 de jan. de 2026, 21:05 UTC

Ganhos

Intuitive Surgical 4Q EPS $2.21 >ISRG

Comparação entre Pares

Variação de preço

Teleflex Inc Previsão

Preço-alvo

By TipRanks

29.37% parte superior

Previsão para 12 meses

Média 133.2 USD  29.37%

Máximo 155 USD

Mínimo 115 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Teleflex Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

7 ratings

1

Comprar

5

Manter

1

Vender

Pontuação Técnica

By Trading Central

122.73 / 135.75Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

No Evidence

Sentimento

By Acuity

174 / 360 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Teleflex Inc

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
help-icon Live chat